Table 3.
Results of multivariable generalised estimating equations (GEE) analysis
| Predictor variable | Adjusted OR (95% CI) |
|---|---|
| HCQ use | |
| No | 1 |
| Yes | 0.46 (0.18 to 1.18) |
| Birth period | |
| ≥2000 | 1 |
| <2000 | 3.28 (1.45 to 7.45) |
| Non-fluorinated steroid use | |
| No | 1 |
| Yes | 0.55 (0.25 to 1.19) |
| Race | |
| Caucasian | 1 |
| Non-Caucasian | 1.03 (0.50 to 2.14) |
| Antibody status | |
| Anti-Ro+/La+ or Anti-Ro−/La+ | 1 |
| Anti-Ro+/La− | 1.16 (0.59 to 2.32) |
| Prior child with NL | |
| No | 1 |
| Yes | 0.49 (0.20 to 1.17) |
Estimates of adjusted OR and 95% CIs from a multivariable GEE model including hydroxychloroquine use, birth period, non-fluorinated steroid use, race, antibody status and prior child with NL as predictor variables.
HCQ, hydroxychloroquine; NL, neonatal lupus.